Becton Dickinson and Company
NYSE: BDX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
Updated 2026-06-05
Becton Dickinson and Company (BDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.08B | $1.24B | $1.69B | $1.72B | $1.74B | $1.72B | $1.76B | $1.51B | $1.74B | $1.73B | $2.56B | $2.55B | $2.87B | $3.33B | $3.54B | $4.65B | $2.63B | $2.99B | $3.80B | $3.43B |
| Capital expenditures | $482.10M | $578.73M | $651.29M | $700.69M | $632.47M | $605.26M | $553.64M | $588.00M | $653.00M | $633.00M | $718.00M | $727.00M | $895.00M | $957.00M | $810.00M | $1.23B | $973.00M | $874.00M | $725.00M | $760.00M |
| Depreciation | $405.10M | $441.34M | $477.42M | $470.19M | $502.11M | $504.09M | $510.94M | $546.00M | $562.00M | $891.00M | $1.11B | $1.09B | $1.98B | $2.25B | $2.15B | $2.27B | $2.23B | $2.29B | $2.29B | $2.46B |
| Stock-based comp | $96.03M | $82.72M | $100.58M | $86.57M | $79.37M | $73.36M | $89.05M | $100.00M | $113.00M | $166.00M | $196.00M | $174.00M | $322.00M | $261.00M | $244.00M | $237.00M | $233.00M | $259.00M | $247.00M | $258.00M |
| Free cash flow | $594.30M | $661.71M | $1.04B | $1.02B | $1.11B | $1.11B | $1.21B | $919.00M | $1.09B | $1.10B | $1.84B | $1.82B | $1.97B | $2.37B | $2.73B | $3.42B | $1.66B | $2.12B | $3.07B | $2.67B |
| Investing cash flow | $-786.53M | $-1.02B | $-783.02M | $-1.07B | $-705.63M | $-1.04B | $-900.11M | $-523.00M | $-948.00M | $-8.32B | $-669.00M | $-883.00M | $-15.83B | $-741.00M | $-1.23B | $-1.88B | $-3.22B | $-716.00M | $-5.51B | $-818.00M |
| Financing cash flow | $-342.17M | $-726.03M | $-585.83M | $-79.70M | $-1.22B | $-714.38M | $-370.17M | $-968.00M | $-807.00M | $6.19B | $-1.76B | $10.98B | $-57.00M | $-3.22B | $22.00M | $-3.31B | $-591.00M | $-1.96B | $2.09B | $-3.62B |
| Dividends paid | $212.43M | $239.81M | $278.51M | $316.88M | $345.71M | $361.20M | $367.61M | $386.00M | $421.00M | $485.00M | $562.00M | $677.00M | $927.00M | $984.00M | $1.03B | $1.05B | $1.08B | $1.11B | $1.10B | $1.20B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-40.71M | — | $219.00M | $-29.00M | — | $117.00M | $12.64B | $-13.04B | — | $2.33B | $-539.00M | $-1.49B | — | — | — |
Frequently asked questions
What is Becton Dickinson and Company's revenue?
Becton Dickinson and Company's trailing twelve-month revenue is $22.23B, and consensus projects about $24.31B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is BDX?
In its most recent fiscal year, BDX ran a gross margin of 45.44%, an operating margin of 11.80%, and a net margin of 7.68%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does BDX generate?
BDX produced $2.67B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is BDX's balance sheet healthy?
BDX holds $851.00M in cash and equivalents against $17.62B in long-term debt, on $25.39B of shareholder equity. That debt is best read against the cash flow the business throws off each year.